Works matching DE "ABACAVIR"

Results: 230
    1
    2
    3

    Abacavir Drug Exposures in African Children Under 14 kg Using Pediatric Solid Fixed Dose Combinations According to World Health Organization Weight Bands.

    Published in:
    Journal of the Pediatric Infectious Diseases Society, 2023, v. 12, n. 11, p. 574, doi. 10.1093/jpids/piad082
    By:
    • Chupradit, Suthunya;
    • Wamalwa, Dalton C;
    • Maleche-Obimbo, Elizabeth;
    • Kekitiinwa, Adeodata R;
    • Mwanga-Amumpaire, Juliet;
    • Bukusi, Elizabeth A;
    • Nyandiko, Winstone M;
    • Mbuthia, Joseph K;
    • Swanson, Alistair;
    • Team, DNDi Clinical;
    • Cressey, Tim R;
    • Punyawudho, Baralee;
    • Musiime, Victor
    Publication type:
    Article
    4
    5
    6
    7

    Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single‐tablet regimen in a multicentre cohort in Spain.

    Published in:
    Journal of the International AIDS Society, 2021, v. 24, n. 7, p. 1, doi. 10.1002/jia2.25758
    By:
    • Suárez‐García, Inés;
    • Alejos, Belén;
    • Ruiz‐Algueró, Marta;
    • García Yubero, Cristina;
    • Moreno, Cristina;
    • Bernal, Enrique;
    • Pérez‐Is, Laura;
    • Zubero, Zuriñe;
    • Zárraga Fernández, Miguel Alberto;
    • Samperiz Abad, Gloria;
    • Jarrín, Inma
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 9, p. 2536
    By:
    • Podzamczer, D.;
    • Imaz, A.;
    • Perez, I.;
    • Viciana, P.;
    • Valencia, E.;
    • Curto, J.;
    • Martín, T.;
    • Castaño, M.;
    • Rojas, J.;
    • Espinosa, N.;
    • Moreno, V.;
    • Asensi, V.;
    • Iribarren, J. A.;
    • Clotet, B.;
    • Force, L.;
    • Bachiller, P.;
    • Knobel, H.;
    • López Bernaldo De Quirós, J. C.;
    • Blanco, J. R.;
    • Rozas, N.
    Publication type:
    Article
    21
    22

    Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 10, p. 2199, doi. 10.1093/jac/dkt200
    By:
    • Fourati, Slim;
    • Visseaux, Benoit;
    • Armenia, Daniele;
    • Morand-Joubert, Laurence;
    • Artese, Anna;
    • Charpentier, Charlotte;
    • Van Den Eede, Peter;
    • Costa, Giosuè;
    • Alcaro, Stefano;
    • Wirden, Marc;
    • Perno, Carlo Federico;
    • Ceccherini Silberstein, Francesca;
    • Descamps, Diane;
    • Calvez, Vincent;
    • Marcelin, Anne-Genevieve
    Publication type:
    Article
    23
    24
    25

    Shaping drug hypersensitivity.

    Published in:
    Nature Immunology, 2012, v. 13, n. 8, p. 721, doi. 10.1038/ni.2381
    By:
    • Fehervari, Zoltan
    Publication type:
    Article
    26
    27
    28
    29

    Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57).

    Published in:
    Open Forum Infectious Diseases, 2022, v. 9, n. 3, p. 1, doi. 10.1093/ofid/ofab595
    By:
    • Podzamczer, D;
    • Micán, R;
    • Tiraboschi, J;
    • Portilla, J;
    • Domingo, P;
    • Llibre, J M;
    • Ribera, E;
    • Vivancos, M J;
    • Morano, L;
    • Masiá, M;
    • Gómez, C;
    • Fanjul, F;
    • Payeras, A;
    • Inciarte, A;
    • Estrada, V;
    • Rivero, A;
    • Castro, Á;
    • Bernal, E;
    • Vinuesa, D;
    • Knobel, H
    Publication type:
    Article
    30

    Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/Abacavir/Lamivudine and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: GESIDA 9016.

    Published in:
    Open Forum Infectious Diseases, 2020, v. 7, n. 12, p. 1, doi. 10.1093/ofid/ofaa482
    By:
    • Valero, Ignacio Perez;
    • Cabello, Alfonso;
    • Ryan, Pablo;
    • Fuente-Moral, Sara De La;
    • Santos, Ignacio;
    • Vivancos, Maria Jesus;
    • Gonzalez, Alicia;
    • Gorgolas, Miguel;
    • Cuevas, Guillermo;
    • Santiago, Alberto Diaz De;
    • Cano, Joanna;
    • Rua, Guadalupe;
    • Yllescas, Maria;
    • García, Juan Julian González
    Publication type:
    Article
    31

    ERRATUM.

    Published in:
    2017
    Publication type:
    Correction Notice
    32
    33
    34

    BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022.

    Published in:
    HIV Medicine, 2022, v. 23, p. 3, doi. 10.1111/hiv.13446
    By:
    • Waters, Laura;
    • Winston, Alan;
    • Reeves, Iain;
    • Boffito, Marta;
    • Churchill, Duncan;
    • Cromarty, Ben;
    • Dunn, David;
    • Fink, Douglas;
    • Fidler, Sarah;
    • Foster, Caroline;
    • Fox, Julie;
    • Gupta, Ravi;
    • Hilton, Andy;
    • Khoo, Saye;
    • Leen, Clifford;
    • Mackie, Nicola;
    • Naous, Nadia;
    • Ogbonmwan, Daisy;
    • Orkin, Chloe;
    • Panton, Linda
    Publication type:
    Article
    35
    36
    37
    38

    Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort.

    Published in:
    HIV Medicine, 2018, v. 19, n. 4, p. 252, doi. 10.1111/hiv.12573
    By:
    • Roen, A.;
    • Laut, K.;
    • Pelchen‐Matthews, A.;
    • Borodulina, E.;
    • Caldeira, L.;
    • Clarke, A.;
    • Clotet, B.;
    • d'Arminio Monforte, A.;
    • Fätkenheuer, G.;
    • Gatell Artigas, J. M.;
    • Karpov, I.;
    • Kuznetsova, A.;
    • Kyselyova, G.;
    • Mozer‐Lisewska, I.;
    • Mulcahy, F.;
    • Ragone, L.;
    • Scherrer, A.;
    • Uzdaviniene, V.;
    • Vandekerckhove, L.;
    • Vannappagari, V.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50